Article Versions Notes

Lee J, Kang J, Kwon N-Y, Sivaraman A, Naik R, Jin S-Y, Oh AR, Shin J-H, Na Y, Lee K, et al. Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents. Pharmaceutics. 2021; 13(4):559. https://doi.org/10.3390/pharmaceutics13040559

Lee, Jaeok, Jiyeon Kang, Na-Yun Kwon, Aneesh Sivaraman, Ravi Naik, So-Young Jin, A. Reum Oh, Jae-Ho Shin, Younghwa Na, Kyeong Lee, and et al. 2021. "Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents" Pharmaceutics 13, no. 4: 559. https://doi.org/10.3390/pharmaceutics13040559

Lee, J., Kang, J., Kwon, N.-Y., Sivaraman, A., Naik, R., Jin, S.-Y., Oh, A. R., Shin, J.-H., Na, Y., Lee, K., & Lee, H.-J. (2021). Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents. Pharmaceutics, 13(4), 559. https://doi.org/10.3390/pharmaceutics13040559